ZA941958B - Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition - Google Patents

Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition

Info

Publication number
ZA941958B
ZA941958B ZA941958A ZA941958A ZA941958B ZA 941958 B ZA941958 B ZA 941958B ZA 941958 A ZA941958 A ZA 941958A ZA 941958 A ZA941958 A ZA 941958A ZA 941958 B ZA941958 B ZA 941958B
Authority
ZA
South Africa
Prior art keywords
protein
purification
pharmaceutical composition
reagent kit
steptococcus
Prior art date
Application number
ZA941958A
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of ZA941958B publication Critical patent/ZA941958B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA941958A 1993-03-19 1994-03-21 Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition ZA941958B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19

Publications (1)

Publication Number Publication Date
ZA941958B true ZA941958B (en) 1995-01-27

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941958A ZA941958B (en) 1993-03-19 1994-03-21 Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition

Country Status (18)

Country Link
US (1) US5869064A (ja)
EP (1) EP0656014B1 (ja)
JP (1) JP3976334B2 (ja)
KR (1) KR100331358B1 (ja)
CN (1) CN1046291C (ja)
AT (1) ATE240351T1 (ja)
CA (1) CA2158658A1 (ja)
DE (1) DE69432658T2 (ja)
DK (1) DK0656014T3 (ja)
ES (1) ES2194024T3 (ja)
HK (1) HK1008825A1 (ja)
HU (1) HU217582B (ja)
NZ (1) NZ263275A (ja)
PT (1) PT656014E (ja)
SG (1) SG47049A1 (ja)
SI (1) SI0656014T1 (ja)
WO (1) WO1994021685A1 (ja)
ZA (1) ZA941958B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
CN1944652A (zh) 1998-02-20 2007-04-11 益德生物医药公司 B组链球菌抗原
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
SI1140994T1 (sl) * 1998-12-22 2005-12-31 Microscience Ltd Proteini zunanje povrsine, njihovi geni in njihova uporaba
NZ512297A (en) * 1998-12-22 2003-12-19 Microscience Ltd Genes and proteins of group a strep, and their use
CN1191362C (zh) * 1998-12-23 2005-03-02 夏尔生化公司 新颖的链球菌抗原
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
WO2002099133A1 (fr) * 2001-05-31 2002-12-12 Fuso Pharmaceutical Industries, Ltd. Procede ameliore de detection et d'identification de micro-organismes causes d'infections
WO2002101037A1 (fr) * 2001-05-31 2002-12-19 Fuso Pharmaceutical Industries, Ltd. Procede d'evaluation de la fonction de phagocytose et utilisation associee
CA2475821C (en) * 2002-02-11 2011-12-13 Shire Biochem Inc. Group b streptococcus antigens
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
PL2144924T3 (pl) 2007-04-16 2017-06-30 Minervax Aps Szczepionka z białkiem fuzyjnym
EP3365003A1 (en) 2015-10-21 2018-08-29 Minervax APS Immunogenic fusion protein
US10888610B2 (en) 2015-12-30 2021-01-12 Minerv Ax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
US20200254083A1 (en) 2017-06-16 2020-08-13 Glaxosmithkline Biologicals Sa Method of treatment
JP2023503086A (ja) 2019-11-22 2023-01-26 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 細菌サッカリド複合糖質ワクチンの用法及び用量
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
WO1992017588A2 (en) * 1991-03-29 1992-10-15 Ervin Faulmann METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI

Also Published As

Publication number Publication date
SG47049A1 (en) 1998-03-20
HUT72841A (en) 1996-05-28
PT656014E (pt) 2003-09-30
WO1994021685A1 (en) 1994-09-29
KR960701096A (ko) 1996-02-24
AU6389194A (en) 1994-10-11
AU681130B2 (en) 1997-08-21
HK1008825A1 (en) 1999-05-21
SI0656014T1 (en) 2003-12-31
HU217582B (hu) 2000-02-28
US5869064A (en) 1999-02-09
NZ263275A (en) 1997-07-27
JPH09500092A (ja) 1997-01-07
HU9501993D0 (en) 1995-08-28
KR100331358B1 (ko) 2002-08-13
DE69432658T2 (de) 2004-04-08
CA2158658A1 (en) 1994-09-29
ES2194024T3 (es) 2003-11-16
EP0656014A1 (en) 1995-06-07
JP3976334B2 (ja) 2007-09-19
DK0656014T3 (da) 2003-08-11
EP0656014B1 (en) 2003-05-14
ATE240351T1 (de) 2003-05-15
DE69432658D1 (de) 2003-06-18
CN1046291C (zh) 1999-11-10
CN1119442A (zh) 1996-03-27

Similar Documents

Publication Publication Date Title
ZA941958B (en) Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
AU1672388A (en) Expression of human proapolipoprotein a-i
AU1026692A (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
ATE323721T1 (de) Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
NO20006191L (no) Vaksine
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
GR3034766T3 (en) Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections.
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
GB9814538D0 (en) Helicobacter pylori bacterioferritin
GB9409985D0 (en) Vaccine against mycobacterial infections
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
EP0237676A3 (en) Recombinant ricin toxin
SE9301207D0 (sv) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
IL93035A0 (en) Plasminogen activator,dna sequence encoding the amino sequence thereof,process for the preparation thereof and pharmaceutical composition containing the same
Pasargiklian et al. Laboratory evaluation of a radiometric system.